PCS
TLIS

Personal CFO Solutions’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Personal CFO Solutions’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-667
Closed -$40K – 525
2021
Q4 		$40K Sell
667
-466
-41% -$34.9K 0.01% 468
2021
Q3 		$106K Buy
+1,133
New +$151K 0.02% 436

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Personal CFO Solutions's TLIS Position: Q1 2022 in Review

Personal CFO Solutions sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q1 2022, closing a stake of 667 shares — an estimated $40K sold.

Personal CFO Solutions first reported a position in TLIS in Q3 2021 and held it in 2 quarters. The position peaked at $106K in Q3 2021. 44 funds tracked by Wall St. Rank hold TLIS as of Q1 2022.

  • Personal CFO Solutions reported no remaining Talis Biomedical Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
  • Personal CFO Solutions sold 667 Talis Biomedical Corporation Common Stock shares in Q1 2022, an estimated $40K.
  • Personal CFO Solutions first reported a position in Talis Biomedical Corporation Common Stock in Q3 2021 and held it in 2 quarters.
  • Personal CFO Solutions's Talis Biomedical Corporation Common Stock position peaked at $106K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q1 2022.

Based on Personal CFO Solutions's 13F filing for Q1 2022, filed 2 May 2022.